Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
08/2012
08/09/2012WO2012106669A2 Foxc1 antibodies and methods of their use
08/09/2012WO2012105794A2 Magnetic nanoparticle, having a curie temperature which is within biocompatible temperature range, and method for preparing same
08/09/2012WO2012104277A2 Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles.
08/09/2012WO2012104275A2 Nanoparticles delivery systems, preparation and uses thereof
08/09/2012WO2012024592A3 Compositions, methods, and systems comprising fluorous-soluble polymers
08/09/2012WO2012021788A3 Dipeptide calpain inhibitors
08/09/2012US20120204276 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis
08/09/2012US20120204274 Bitransgenic murine model for studying myelopoiesis, immunity and tumorigenesis
08/09/2012US20120204273 Compositions relating to a phosphoprotein and methods of use
08/09/2012US20120203102 Azulene and azaazulene systems for imaging, monitoring and therapy
08/09/2012US20120202751 Methods of monitoring endoplasmic reticulum (er) stress response
08/09/2012US20120201760 Metal oxide particles coated with polyethylene glycol and their synthesis
08/09/2012US20120201758 Process for producing food
08/09/2012US20120201757 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide
08/09/2012US20120201756 Plasma kallikrein binding proteins
08/09/2012US20120201755 Sensor system
08/09/2012US20120201753 Methods and compositions related to targeting wounds, regenerating tissue, and tumors
08/09/2012US20120201752 Foxc1 antibodies and methods of their use
08/09/2012US20120201749 NP-1 Antagonists and Their Therapeutic Use
08/09/2012CA2826144A1 Foxc1 antibodies and methods of their use
08/09/2012CA2825564A1 Nanoparticles delivery systems, preparation and uses thereof
08/08/2012EP2484344A2 Compositions and methods of using microspheres and non-ionic contrast agents
08/08/2012EP2482857A1 Hydroxylated contrast enhancement agents and intermediates thereof
08/08/2012EP2482856A2 Micellar compositions for use in biological applications
08/08/2012EP2482833A1 Leptin agonist and methods of use
08/08/2012EP2152369B1 Use of fluoride-containing compounds for diagnostic purposes with the help of imaging processes
08/08/2012EP2001520B1 Diagnostic systems and methods utilizing probe-ions exhibiting photon avalanche effect
08/08/2012CN1901936B Cytotoxicity mediation of cells evidencing surface expression of cd44
08/08/2012CN102627615A Novel compound L-4-terazine-phenylalanine, preparation method and application thereof
08/08/2012CN102626519A Targeting multifunctional carbon nanotube / polyethylenimine drug delivery carrier, and preparation method and application thereof
08/08/2012CN102178962B Medical disinfection/sterilization ultrasound couplant and preparation method thereof
08/08/2012CN102167813B Fluorescent tracing nanometer magnetic resonance imaging contrast agent
08/07/2012US8236541 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
08/07/2012US8236283 Optical imaging
08/07/2012CA2447367C Diagnosis and treatment of malignant neoplasms
08/02/2012WO2012102799A2 Method, composition and package for bowel cleansing
08/02/2012WO2012102363A1 Drug delivery system and use of same
08/02/2012WO2012078813A3 Novel modulators and methods of use
08/02/2012WO2012075241A3 Protease degradable polypeptides and uses thereof
08/02/2012US20120197115 Spectral magnetic particle imaging
08/02/2012US20120197114 Nanocarriers for imaging and therapy applications
08/02/2012US20120195835 Tumor tissue-selective bio-imaging nanoparticles
08/02/2012US20120195834 Method of testing a drug for anti-cancer activity
08/02/2012US20120195833 Medical Contrast Agent Made of Microbubbles Containing Fluorescent Gold Nanoclusters
08/02/2012US20120195832 Process for producing an injectable medicament preparation
08/02/2012US20120195831 Generation, characterization and uses thereof of anti-her3 antibodies
08/02/2012US20120195829 Methods for identifying targeting domains and method and compositions comprising the same
08/02/2012US20120195828 Kidney-imaging agent comprising recombinant gelatin
08/02/2012US20120195827 Myocardial perfusion imaging methods and compositions
08/02/2012CA2825808A1 Method, composition and package for bowel cleansing
08/01/2012EP2481710A1 Polymer-coated ferrite microparticles and production method for same
08/01/2012EP2481420A1 Single dose anti-PCV2 pig vaccine
08/01/2012EP2480257A2 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13)
08/01/2012EP1133310B1 Artery- and vein-specific proteins and uses therefor
08/01/2012EP0961612B2 Protein stabilized pharmacologically active agents and their use
08/01/2012CN102618562A Neukinase, a downstream protein of neuregulin
08/01/2012CN102617556A Novel 2-heteroaryl substituted benzothiophenes and benzofuranes 709
08/01/2012CN102614535A Medical contrast agent and manufacuture method for microbubbles containing fluorescent gold nanoclusters
08/01/2012CN102614534A Treatment diagnosis preparation based on gold nanoshell coated polymer microcapsule, and preparation method thereof
08/01/2012CN102614533A Method for preparing water-soluble manganese oxide magnetic resonance contrast agent and application thereof
08/01/2012CN102614532A Multifunctional tumor imaging agent, preparation method and application
08/01/2012CN102614531A Multi-core non-ion type magnetic resonance imaging contrast agent using diacetyl benzene or triacetyl benzene as linker
08/01/2012CN102614530A Traditional Chinese medical capsule for auxiliary examination of early tumor on inner wall of small intestine
08/01/2012CN102085381B Ferroferric oxide-silicon dioxide-thymine nanoparticles and preparation method and application thereof
08/01/2012CN101966343B Carbon nanotube/magnetic nanoparticle magnetic resonance contrast medium and preparation method thereof
07/2012
07/31/2012US8231890 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
07/31/2012US8231868 Method for suppressing immune system response to transplanted tissue or cells
07/31/2012US8231862 RBP4 in insulin sensitivity/resistance, diabetes, and obesity
07/31/2012US8231861 Identifying candidate therapeutic agents for use in the treatment of acute pancreatitis; drug screening; Toll-Like Receptor 4 (TLR4)
07/31/2012US8231860 Detecting microspheres trapped within bronchoalveolar macrophages as indicative of pulmonary aspiration or gastroesophageal reflux; using biodegradable polymers mixed in food; sensitivity; preventing respiratory disorders
07/31/2012CA2489965C Pharmaceutical compositions for the treatment of diseases related to neurotrophines
07/31/2012CA2459896C A method for evaluation of tissue adhesion level
07/26/2012WO2012100206A2 Mri markers, delivery and extraction systems, and methods of manufacture and use thereof
07/26/2012WO2012099983A1 Nav1.7 knockout mice and uses thereof
07/26/2012WO2012098226A2 Visualization of lipid metabolism
07/26/2012WO2012098166A1 Indicator for ascertaining the state of skin
07/26/2012WO2012097801A1 Method for generating a contrast medium-assisted x-ray image and x-ray system
07/26/2012US20120192295 Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof
07/26/2012US20120192294 Inhibitors of the Nitration of Amyloid Beta Peptides and Their Uses in the Diagnosis and Treatment of Alzheimer's Disease
07/26/2012US20120190975 Nanoparticles for use in tumor diagnosis and therapy
07/26/2012US20120190560 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
07/26/2012US20120189554 Multi-functional drug carriers
07/26/2012US20120189552 Compositions and methods using microspheres and non-ionic contrast agents
07/26/2012US20120189551 MRI Markers, Delivery and Extraction Systems, and Methods of Manufacture and Use Thereof
07/26/2012US20120189550 Orally administered bacteria as vehicles for systematic delivery of agents
07/26/2012US20120189549 Device for automating behavioral experiments on animals
07/26/2012US20120189545 Isotopically-labeled benzofuran compounds as imaging agents for amyloidogenic proteins
07/26/2012US20120189543 Compositions and Methods for Detecting and Treating Implant Loosening and Osteolysis
07/26/2012CA2824521A1 Mri markers, delivery and extraction systems, and methods of manufacture and use thereof
07/26/2012CA2823707A1 Nav1.7 knockout mice and uses thereof
07/25/2012EP2479290A2 Methods for the administration of iloperidone
07/25/2012EP2478913A1 Synthetic HLA binding peptide analogues and uses thereof
07/25/2012EP2478357A1 Use of alpha-methylglucoside (amg) as an indicator for glucose absorption and excretion
07/25/2012CN102604629A Preparation method and applications of amino carbon quantum dots
07/25/2012CN102604628A Preparation method and applications of organic-inorganic hybrid phosphorescent silica nanoparticles
07/25/2012CN102604065A Cross-linked biologically degradable carrier polymer, micelle and vesicle, and preparation method and application of the cross-linked biologically degradable carrier polymer, micelle and vesicle
07/25/2012CN102603649A Fluorescence probe compound taking dibazole as guide molecule and preparation method thereof
07/25/2012CN102600486A Medical ultrasonic coupling agent and preparation method thereof
07/25/2012CN102600485A Ultrasonic contrast medium dosage formula
07/25/2012CN102600484A Application of shikonin serving as endoscope staining agent, and endoscope staining composition
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 354